oxazoles has been researched along with Sarcoma 180 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amano, H; Hayashi, I; Inukai, M; Kamata, M; Kitasato, H; Majima, M; Yoshida, S; Yoshimura, H | 1 |
| Hemsworth, GR; Jensen, KE; Kraska, AR; Wolff, JS | 1 |
| Ashizawa, T; Fujimoto, K; Hirata, T; Kasai, M; Morimoto, M; Saito, H; Sato, A | 1 |
| Bierling, R; Maral, R; Pütter, J; Steinhoff, D | 1 |
4 other study(ies) available for oxazoles and Sarcoma 180
| Article | Year |
|---|---|
COX-2/VEGF-dependent facilitation of tumor-associated angiogenesis and tumor growth in vivo.
Topics: Animals; Antibodies, Blocking; Aspirin; Benzenesulfonates; Carcinoma, Lewis Lung; Cyclooxygenase Inhibitors; Disease Models, Animal; Endothelial Growth Factors; Intercellular Signaling Peptides and Proteins; Isoxazoles; Lymphokines; Male; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neovascularization, Pathologic; Nitrobenzenes; Oxazoles; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoma 180; Sulfonamides; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Delayed cutaneous hypersensitivity to oxazolone in mice with tumors.
Topics: Animals; Carmustine; Doxorubicin; Female; Hypersensitivity, Delayed; Leukemia, Experimental; Leukemia, Lymphoid; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Oxazoles; Oxazolone; Sarcoma 180; Skin | 1978 |
Synthesis and biological evaluation of quinocarcin derivatives: thioalkyl-substituted quinones and hydroquinones.
Topics: Animals; Antibiotics, Antineoplastic; Benzoquinones; Chemical Phenomena; Chemistry; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Leukemia P388; Mice; Mice, Inbred BALB C; Oxazoles; Sarcoma 180; Structure-Activity Relationship | 1991 |
Resarch on new Schiff bases with antiblastic activity. Carcinostatic activities of 3-p-(2',5'-dimethoxy-4'-(N,N-bis( -chloroethyl)-amino)benzylideneamino)phenyl-2-oxazolidinone (GEA 29 = BAY a 5850).
Topics: Amines; Aniline Compounds; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Chemical Phenomena; Chemistry; Cricetinae; Erythropoiesis; Hematopoiesis; Leukemia; Leukocytes; Mice; Neoplasm Transplantation; Nitrogen Mustard Compounds; Oxazoles; Rats; Retroviridae; Sarcoma 180; Sarcoma, Experimental; Schiff Bases | 1971 |